Medpace shareholders approve board declassification; annual director elections start 2025

Medpace Holdings, Inc.

Stockholders approved amendment to phase out classified board; directors elected annually beginning at 2025 annual meeting.
Fred B. Davenport Jr. and Cornelius P. McCarthy III elected as Class II directors through 2027.
Deloitte & Touche ratified as independent auditor for fiscal year ending December 31, 2024.
Advisory say-on-pay proposal on named executive officer compensation approved.
Charter amendment and bylaw amendments became effective May 17, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.